Key Oxycodone Drugs Market Trend for 2025-2034: Focus On Developing Immediate-Release Tablets To Combat Drug Abuse In Oxycodone Drug Market

What Is the Future Outlook for the Oxycodone Drugs Market's Size and Growth Rate?
The market for oxycodone drugs has experienced robust growth in the past few years. The size of the market is projected to escalate from $5.62 billion in 2024 to $6.04 billion in 2025, with a compound annual growth rate (CAGR) of 7.4%. The historical period's growth is mainly due to an intensive marketing strategy for OxyContin. This drug was promoted for both chronic non-malignant pain and cancer, resulting in a surge in OxyContin's prescriptions for non-cancer-related pain, thereby increasing the demand for these drugs. Additionally, synthetic opiates like oxycodone have gained more presence in the market following the Second World War.

In the coming years, the oxycodone drugs market is anticipated to experience robust growth. It is predicted to expand up to $7.92 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.0%. This forecasted growth can be credited to a surge in chronic pain prevalence, an increased number of surgeries, ongoing product pipeline developments, advances in drug delivery systems, and a globally expanding elderly population experiencing an increased rate of chronic pain. Over the forecast period, the market will be dominated by trends such as the heightened demand for abuse-deterrent formulations (ADFS), the emergence of innovative delivery systems, the increased application of combination therapies, and technological progress in production processes.

What Key Elements Are Boosting Growth in the Oxycodone Drugs Market?
The escalating prevalence of orthopedic disorders is projected to fuel the expansion of the oxycodone drug market. Orthopedic disorders consist of a variety of musculoskeletal conditions such as bone, joint, ligament, tendon, and muscle ailments that result in pain, reduced mobility, and functional restrictions. The surge in orthopedic disorders can be attributed to factors like aging populations, sedentary lifestyles, obesity, sporting injuries, and occupational hazards. Oxycodone drugs prove effective in treating orthopedic disorders by alleviating severe and chronic pain caused by circumstances like bone fractures, joint injuries, or discomfort following surgery, as they act on the pain receptors in the central nervous system. For example, in October 2023, the Institute for Health Metrics and Evaluation, a research institution based in the US, predicts that the number of musculoskeletal disorders (orthopedic disorders) is expected to increase by 115% (ranging from 107-124%) from 2020 to 2050, reaching a projected 1,060 million prevalent cases by 2050. Hence, the heightened prevalence of orthopedic disorders is promoting the growth of the oxycodone drug market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15886&type=smp

Which Key Market Leaders Are Driving Oxycodone Drugs Industry Growth?
Major companies operating in the oxycodone drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Purdue Pharma L.P, Endo International plc, Amneal Pharmaceuticals LLC, Mundipharma Pty Limited, Alkermes plc, Mallinckrodt Pharmaceuticals, Alvogen Group Inc., Collegium Pharmaceutical Inc., Lannett Company Inc., Acorda Therapeutics Inc., Camurus AB, Rhodes Pharmaceuticals L.P., KVK Tech Inc., Teikoku Pharma USA Inc., Manus Aktteva Biopharma LLP, Zyla Life Sciences

What Are the Emerging Trends in the Oxycodone Drugs Industry?
Prominent players in the oxycodone drug market are concentrating their resources on the creation of innovative medications such as immediate-release (IR) oxycodone tablets. This is an attempt to curb misuse by injection and through the intranasal route. The oxycodone IR tablets are an iteration of the opioid painkiller oxycodone, crafted to deliver speedy alleviation of pain. For instance, RoxyBond (oxycodone), an immediate-release (IR) tablet, was introduced in the United States by Protega Pharmaceuticals LLC, in July 2022. The U.S. Food and Drug Administration (FDA) has officially approved RoxyBond as an opioid agonist for managing severe pain, which requires the use of an opioid analgesic when other avenues come up short. This product is built using sophisticated technology to discourage misuse and abuse, making it challenging to manipulate either physically or chemically.

What Are the Main Segments in the Oxycodone Drugs Market?
The oxycodone drugs market covered in this report is segmented -

1) By Drug Type: Short Acting Oxycodone, Long Acting Oxycodone
2) By Dosage Form: Tablets, Capsules, Injections
3) By Indication: Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Post Operative Pain, Other Indications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Short Acting Oxycodone: Immediate-Release Oxycodone Tablets, Oxycodone Oral Solution
2) By Long Acting Oxycodone: Extended-Release Oxycodone Tablets, Oxycodone Controlled-Release Formulations

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report

Which Geographic Area Leads the Oxycodone Drugs Market?
North America was the largest region in the oxycodone drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oxycodone drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The Oxycodone Drugs Global Market Report?

- Market Size Analysis: Analyze the Oxycodone Drugs Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Oxycodone Drugs Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Oxycodone Drugs Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Oxycodone Drugs Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15886

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.